The Selective Cyclooxygenase-2-Inhibitor Rofecoxib may Improve the Treatment of Chronic Idiopathic Urticaria

Boehncke, W.-H. and Ludwig, R.J. and Zollner, T.M. and Ochsendorf, F. and Kaufmann, R. and Gibbs, B.F. (2003) The Selective Cyclooxygenase-2-Inhibitor Rofecoxib may Improve the Treatment of Chronic Idiopathic Urticaria. british journal of dermatology, 148 (3). pp. 604-606. ISSN 0007-0963.

The full text of this publication is not available from this repository. (Contact us about this Publication)
Item Type: Article
Subjects: R Medicine
Q Science > QR Microbiology > QR180 Immunology
Divisions: Faculties > Science Technology and Medical Studies > Medway School of Pharmacy
Depositing User: Bernhard F- Gibbs
Date Deposited: 05 Sep 2008 12:40
Last Modified: 14 Jan 2010 14:17
Resource URI: http://kar.kent.ac.uk/id/eprint/4812 (The current URI for this page, for reference purposes)
  • Depositors only (login required):